Takumoto, Yuki; Sasahara, Yuriko; Narimatsu, Hiroto; … - In: Health economics review 12 (2022) 1, pp. 1-12
Backgrounds Limited information is available on the utility values of metastatic pancreatic cancer, focusing on diferent health statuses, selected chemotherapy, and related grades 1/2 and 3/4 adverse events (AEs). We evaluated Japanese societal-based health-related utility values for metastatic...